PROGNOSTIC VALUE OF BREAST CANCER SUBTYPES BASED ON ER/PR, HER2 EXPRESSION AND KI-67 INDEX IN WOMEN RECEIVED ADJUVANT THERAPY AFTER CONSERVATIVE SURGERY FOR EARLY STAGES BREAST CANCER A RETROSPECTIVE CLINICAL STUDY

Fouda MennaAllah

首页> 外文期刊>The Breast : >PROGNOSTIC VALUE OF BREAST CANCER SUBTYPES BASED ON ER/PR, HER2 EXPRESSION AND KI-67 INDEX IN WOMEN RECEIVED ADJUVANT THERAPY AFTER CONSERVATIVE SURGERY FOR EARLY STAGES BREAST CANCER A RETROSPECTIVE CLINICAL STUDY

【24h】

PROGNOSTIC VALUE OF BREAST CANCER SUBTYPES BASED ON ER/PR, HER2 EXPRESSION AND KI-67 INDEX IN WOMEN RECEIVED ADJUVANT THERAPY AFTER CONSERVATIVE SURGERY FOR EARLY STAGES BREAST CANCER A RETROSPECTIVE CLINICAL STUDY

机译：基于ER / PR的乳腺癌亚型的预后价值，女性乳腺癌的乳腺癌患者治疗乳腺癌保守治疗乳腺癌的回顾性临床研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Breast :》 |2018年第1期|共1页
作者
Fouda MennaAllah;
展开▼
作者单位

Tanta Univ Hosp Clin Oncol &

Nucl Med Dept Tanta Egypt;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类胸部外科学;
关键词

相似文献

外文文献
中文文献
专利

1. PROGNOSTIC VALUE OF BREAST CANCER SUBTYPES BASED ON ER/PR, HER2 EXPRESSION AND KI-67 INDEX IN WOMEN RECEIVED ADJUVANT THERAPY AFTER CONSERVATIVE SURGERY FOR EARLY STAGES BREAST CANCER A RETROSPECTIVE CLINICAL STUDY [J] . Fouda MennaAllah The Breast : . 2018,第Suppla1期

机译：基于ER / PR的乳腺癌亚型的预后价值，女性乳腺癌的乳腺癌患者治疗乳腺癌保守治疗乳腺癌的回顾性临床研究
2. PROGNOSTIC VALUE OF BREAST CANCER SUBTYPES BASED ON ER/PR, HER2 EXPRESSION AND KI-67 INDEX IN WOMEN RECEIVED ADJUVANT THERAPY AFTER CONSERVATIVE SURGERY FOR EARLY STAGES BREAST CANCER A RETROSPECTIVE CLINICAL STUDY [J] . Fouda MennaAllah The Breast : . 2018,第期

机译：基于ER / PR的乳腺癌亚型的预后价值，女性乳腺癌的乳腺癌患者治疗乳腺癌保守治疗乳腺癌的回顾性临床研究
3. PROGNOSTIC VALUE OF BREAST CANCER SUBTYPES BASED ON ER/PR, HER2 EXPRESSION AND KI-67 INDEX IN WOMEN RECEIVED ADJUVANT THERAPY AFTER CONSERVATIVE SURGERY FOR EARLY STAGES BREAST CANCER A RETROSPECTIVE CLINICAL STUDY [J] . Fouda MennaAllah The Breast : . 2018,第Suppla1期

机译：基于ER / PR的乳腺癌亚型的预后价值，女性乳腺癌的乳腺癌患者治疗乳腺癌保守治疗乳腺癌的回顾性临床研究
4. Elevated WBP2 Expression in HER2-Positive Breast Cancers Correlates with Sensitivity to Trastuzumab-Based Neo-Adjuvant Therapy: A Retrospective and Multicentric Study [C] . Yoon Pin Lim International Molecular Medicine Tri-Conference. . 2019

机译：HER2阳性乳腺癌中的WBP2表达升高与基于曲妥珠单抗的新辅助治疗的敏感性相关：回顾性和多中心研究
5. Boron Neutron Capture Therapy for HER2+ breast cancers: A feasibility study evaluating BNCT for potential role in breast conservation therapies. [D] . Jenkins, Peter Anthony. 2012

机译：HER2 +乳腺癌的硼中子捕获疗法：评估BNCT在乳腺癌保护疗法中潜在作用的可行性研究。
6. Predictive value and clinical utility of centrally-assessed ER PgR and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive HER2-negative early breast cancer: TEXT and SOFT trials [O] . Meredith M. Regan, Olivia Pagani, Prudence A. Francis, -1

机译：集中评估的ERPgR和Ki-67对激素受体阳性HER2阴性的早期绝经前妇女选择辅助内分泌治疗的预测价值和临床实用性：TEXT和SOFT试验
7. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study [O] . Sanpaolo, Pietro, Barbieri, Viviana, Genovesi, Domenico 2011

机译：保守治疗的早期乳腺癌中乳腺癌亚型对乳腺癌特异性存活率，远处转移和局部复发率的预后价值：一项回顾性临床研究
8. Phase II Study of a HER-2/neu (HER2) Intracellular Domain (ICD) Peptide- Based Vaccine Administered to Stage IIIB and IV HER2 Positive Breast Cancer Patients Receiving Trastuzumab Monotherapy; Annual rept. 27 Apr 2007-26 Apr 2008 [R] . Disis, M. L. 2008

机译：对接受曲妥珠单抗单一疗法的IIIB和IV期HER2阳性乳腺癌患者施用HER-2 / neu（HER2）细胞内结构域（ICD）基于肽的疫苗的II期研究;年度报告。 2007年4月27日至2008年4月26日

PROGNOSTIC VALUE OF BREAST CANCER SUBTYPES BASED ON ER/PR, HER2 EXPRESSION AND KI-67 INDEX IN WOMEN RECEIVED ADJUVANT THERAPY AFTER CONSERVATIVE SURGERY FOR EARLY STAGES BREAST CANCER A RETROSPECTIVE CLINICAL STUDY

著录项

相似文献

相关主题

期刊订阅